Callaly, a period care manufacturer, has received 510(k) clearance from the Food and Drug Administration (FDA) for its Callaly Tampliner. Share this:TwitterFacebookLike this:Like Loading... You May Also Like Healthcare Technology 28-05-2021 Digital therapeutic for postpartum depression granted FDA Breakthrough Device Designation Healthcare Technology 01-05-2021 Pre-pandemic, more than half of hospitals win above-average Leapfrog safety grades Healthcare Technology 18-05-2021 Providence posts $222M operating loss in Q1 as COVID-19 surges cause drop in operating revenues Healthcare Technology 11-01-2023 M&A: OpenLoop Acquires Reliant.MD’s Practice Group